• Je něco špatně v tomto záznamu ?

Possible effect of DHA intake on body weight reduction and lipid metabolism in obese children

L. Vasickova, P. Stavek, P. Suchanek,

. 2011 ; 32 Suppl 2 () : 64-7.

Jazyk angličtina Země Švédsko

Typ dokumentu časopisecké články, randomizované kontrolované studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12024252

OBJECTIVES: The aim of the study was to determine whether increased intake of DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid) would affect the weight loss or the various biochemical parameters in the blood of obese children following dietary/physical intervention. There were 120 obese (BMIs≥30 kg/m(2); mean 33.5 ± 3.9) children included in this randomized crossover study; aged 8-12 years (10.0 ± 1.9). METHODS: The children consumed an extra 300 mg DHA and 42 mg EPA (Haliborange ®) daily for a period of 3 weeks. Anthropometric and biochemical parameters were measured and documented for each of the subjects at the beginning of the study, after three weeks of treatment and at the end of the study. RESULTS: The daily consumption of 300 mg DHA and 42 mg of EPA was associated with decreased body weight (with DHA: 86.4 ± 19.6 to 80.8 ± 20.4 kg vs. without DHA: 85.6 ± 20.8 to 80.9 ± 19.9 kg; p<0.005) and total cholesterol concentration (with DHA: 3.72 ± 0.78 to 3.32 ± 0.53 mmol/l vs. without DHA: 3.74 ± 0.78 to 3.56 ± 0.56 mmol/l; p<0.05 and respectively with DHA). CONCLUSION: Daily consumption of 300 mg DHA and 42 mg EPA (Haliborange®) for 3 weeks leads to an improvement of the anthropometric and lipid parameters in obese children following dietary physical intervention.

000      
00000naa a2200000 a 4500
001      
bmc12024252
003      
CZ-PrNML
005      
20121210094827.0
007      
ta
008      
120815s2011 sw f 000 0#eng||
009      
AR
035    __
$a (PubMed)22101886
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Vasickova, Ludmila $u Children's Institute Dr. L. Filip, Podebrady, Czech Republic.
245    10
$a Possible effect of DHA intake on body weight reduction and lipid metabolism in obese children / $c L. Vasickova, P. Stavek, P. Suchanek,
520    9_
$a OBJECTIVES: The aim of the study was to determine whether increased intake of DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid) would affect the weight loss or the various biochemical parameters in the blood of obese children following dietary/physical intervention. There were 120 obese (BMIs≥30 kg/m(2); mean 33.5 ± 3.9) children included in this randomized crossover study; aged 8-12 years (10.0 ± 1.9). METHODS: The children consumed an extra 300 mg DHA and 42 mg EPA (Haliborange ®) daily for a period of 3 weeks. Anthropometric and biochemical parameters were measured and documented for each of the subjects at the beginning of the study, after three weeks of treatment and at the end of the study. RESULTS: The daily consumption of 300 mg DHA and 42 mg of EPA was associated with decreased body weight (with DHA: 86.4 ± 19.6 to 80.8 ± 20.4 kg vs. without DHA: 85.6 ± 20.8 to 80.9 ± 19.9 kg; p<0.005) and total cholesterol concentration (with DHA: 3.72 ± 0.78 to 3.32 ± 0.53 mmol/l vs. without DHA: 3.74 ± 0.78 to 3.56 ± 0.56 mmol/l; p<0.05 and respectively with DHA). CONCLUSION: Daily consumption of 300 mg DHA and 42 mg EPA (Haliborange®) for 3 weeks leads to an improvement of the anthropometric and lipid parameters in obese children following dietary physical intervention.
650    _2
$a antropometrie $7 D000886
650    _2
$a tělesná hmotnost $x účinky léků $x fyziologie $7 D001835
650    _2
$a C-reaktivní protein $x analýza $7 D002097
650    _2
$a dítě $7 D002648
650    _2
$a klinické křížové studie $7 D018592
650    _2
$a kyseliny dokosahexaenové $x farmakologie $x terapeutické užití $7 D004281
650    _2
$a kyseliny mastné omega-3 $x terapeutické užití $7 D015525
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a metabolismus lipidů $x účinky léků $7 D050356
650    _2
$a lipidy $x krev $7 D008055
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a obezita $x dietoterapie $x farmakoterapie $x metabolismus $7 D009765
650    _2
$a hmotnostní úbytek $x účinky léků $7 D015431
655    _2
$a časopisecké články $7 D016428
655    _2
$a randomizované kontrolované studie $7 D016449
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Stavek, Petr
700    1_
$a Suchanek, Pavel
773    0_
$w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 32 Suppl 2(2011), s. 64-7
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22101886 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120815 $b ABA008
991    __
$a 20121210094904 $b ABA008
999    __
$a ok $b bmc $g 946400 $s 781580
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 32 Suppl 2 $d 64-7 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
LZP    __
$a Pubmed-20120815/12/02

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...